Compare Citius Pharmaceuticals Inc (CTXR) vs eBay Inc (EBAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs eBay Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.54 (market cap $14.64M), while eBay Inc trades at $112.92 (market cap $49.97B). The key difference: eBay Inc is far larger — about 3413.3× Citius Pharmaceuticals Inc's market cap, and eBay Inc pays a 1.1% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | EBAY | |
|---|---|---|
Market Cap | $14.64M | $49.97B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $118.96 |
52-Week Low | $0.53 | $76.79 |
Enterprise Value | $10.86M | $53.31B |
Volume | — | 5,186,418 |
Dividend Yield | — | 1.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTXR trades at $0.54, down 7.33% in the last session, with a bearish technical signal from moving averages. The company reported a net loss of $37.43M for 2025 and has missed earnings expectations for the last three quarters. Recent news highlights progress with LYMPHIR, including Phase 1 data presentations at ASCO and international expansion, alongside $5.6M in net revenue for the first half of 2026.
Despite a high analyst buy consensus (83%), CTXR faces significant fundamental challenges with negative profitability and cash burn. Investment opportunity hinges on successful commercialization of LYMPHIR, but risks include ongoing losses, dilution from recent financing, and clinical execution uncertainties. The stock remains speculative with high risk-reward dynamics.
EBAY trades at $115.09, down 1.8% today, amid a bullish technical setup with strong moving average signals and key support at $114. The company shows robust profitability with a 71.79% gross margin and consistent earnings beats, while navigating a potential acquisition by GameStop. Revenue growth is steady, reaching $11.10B in 2025, though net cash flow turned negative.
Outlook remains mixed: strong fundamentals and bullish analyst sentiment (46% buy ratings) support upside, but risks include the uncertain GameStop takeover bid and competitive pressures. The stock trades above the $107.82 consensus target, suggesting limited near-term gains unless earnings surprise again.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →
